Statins may facilitate Parkinson's disease: Insight gained from a large, national claims database.

ABSTRACT:

Objective

Using a large U.S. claims database (MarketScan), we investigated the controversy surrounding the role of statins in Parkinson's disease (PD).

Methods

We performed a retrospective case-control analysis. First, we identified 2322 incident PD cases having a minimum of 2.5 years of continuous enrollment prior to earliest diagnosis code or prescription of antiparkinson medication. A total of 2322 controls were then matched individually by age, gender, and a follow-up window to explore the relationship of statin use with incident PD.

Results

Statin usage was significantly associated with PD risk, with the strongest associations being for lipophilic (odds ratio = 1.58, P < .0001) versus hydrophilic (odds ratio = 1.19, P = .25) statins, statins plus nonstatins (odds

SUBMITTER: Liu G 

PROVIDER: S-EPMC5466869 | biostudies-literature | 2017 Jun

REPOSITORIES: biostudies-literature